Jin-Tae Kim
Seoul, South Korea
NCT Number: NCT03450785
Central venous catheters are frequently used for monitoring haemodynamic status and rapidly delivering fluid therapy during the peri- and postoperative periods. Indwelling central venous catheters are typically used 7-14 days postoperatively for additional monitoring and treatment, but patients may develop asymptomatic catheter-related thrombosis, leading to life-threatening pulmonary embolism and death. Early detection helps to avoid such complications. This prospective observational study investigated the risk factors associated with catheter-related right internal jugular vein thrombosis in pediatric patients. The study enrolled 80 pediatric patients who were scheduled to receive central venous catheter. To detect thrombus formation, Doppler ultrasound examinations from the thyroid cartilage level to the supraclavicular region were used after CVC placement and on each of the following days until the catheter was removed.
Looking for future studies?
Notify MeUp to 6 year
All sexes
Observational
Seoul, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Doppler ultrasound examinations from the thyroid cartilage level to the supraclavicular region were used after CVC placement and on each of the following days until the catheter was removed.
Time frame: after central venous catheter placement and on each of the following days until the catheter was removed (maximum 5 days)
Seoul National University Hospital
Other
Study About the Incidence and Risk Factors of the Central Line Catheter Related Right Internal Jugular Vein Thrombosis in Pediatric Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04541446
Central Line Complication, Central Line Infection
Hershey, Pennsylvania, United States
View Trial DetailsNCT06187831
Bleeding, Blood Platelet Disorders
Lund, Lunds Universitet, Sweden
View Trial DetailsNCT05246709
Central Line Complication, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
New York, United States
View Trial DetailsNCT06652490
Central Line Complication
Cairo, Egypt
View Trial Details